|
|
||||||||
Department of Immunology, University of Washington, Seattle, WA 98195
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A challenge to studying RTEs is their lack of a unique cell surface marker. Recent work from our laboratory (1, 2) characterized a new model system that allows unambiguous identification of RTEs from unmanipulated mice and enables the ready isolation and analysis of their function and phenotype. This system uses mice transgenic (Tg) for GFP under control of the RAG-2 promoter (3). Thymocytes from such RAG2p-GFP Tg mice express high levels of GFP, mirroring endogenous RAG expression. Although RAG expression in RAG2p-GFP Tg mice is extinguished by the single positive (SP) stage, a residual, decaying GFP signal remains in cells following thymic egress. Thymectomy studies have indicated that the GFP signal declines with time in the periphery, such that GFPhigh and GFPlow RTEs have been in the periphery for up to 1 and 2–3 wk, respectively (1). GFP– naive T cells (non-RTEs) have exited the thymus at least 3 wk previously.
Using this system, we demonstrated that RTEs exhibit a CD24highQa2lowCD45RBlowIL-7R
lowTCRhighCD3highCD28low phenotype relative to non-RTEs (1). We also showed that RTEs differ functionally from non-RTEs, exhibiting a dampened response to stimulation, with decreased IL-2 and IFN-
production, proliferation, and high-affinity IL-2R up-regulation (1). These striking differences between RTEs and non-RTEs hint that definable forces may drive cells from RTE status into the mature naive T cell compartment. We now show that RTE maturation occurs progressively, requires egress from the thymus, and is driven to completion not in the blood, but within secondary lymphoid organs (SLOs).
| Materials and Methods |
|---|
|
|
|---|
C57BL/6 mice were from The Jackson Laboratory and RAG2p-GFP Tg mice (3), originally a gift from M. Nussenzweig (The Rockefeller University, New York, NY), were backcrossed in our laboratory at least 10 generations onto the C57BL/6 background. Mice were used between 6 and 12 wk of age. All experiments were performed in compliance with the University of Washingtons Institutional Animal Care and Use Committee.
Mouse procedures
Mice were splenectomized (4) and thymectomized (1) as described previously. For blockade of thymic and lymph node (LN) egress, mice were i.p. injected daily for 3 or 6 days with 1 µg/g body weight 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol (AAL-R), a sphingosine 1-phosphate (S1P) mimetic, or AAL-S (gifts from Novartis), a biologically inactive enantiomer of AAL-R, made up at 1 mg/ml in water plus 0.25% DMSO. For blockade of LN entry, mice were given 200 µg of laboratory-purified anti-CD62L (clone MEL-14) plus 100 µg of anti-very late Ag 4 (VLA-4; clone PS/2) or 200 µg of IgG2a isotype control Ab (eBioscience) i.p. on days 0, 2, and 4.
Cell preparation, staining, enrichment, and sorting
Single cell suspensions of thymus, LNs (brachial, axillary, inguinal, cervical, and mesenteric), and water-lysed blood and splenocytes were prepared and counted. Where noted, cells were labeled for 10 min at 37°C with 4 µm of CFSE. For flow cytometric analysis, Fc receptors were blocked with anti-CD16/32 (clone 2.4G2; BD Biosciences) and cells were stained as described (1) with Abs against the following molecules: CD3 (clone 145.2C11), CD4 (clone RM4-5), CD11c (clone N418), CD24 (clone M1/69), CD25 (clone PC61), CD44 (clone Pgp-1), CD45.1 (clone A20), CD45.2 (clone 104), CD45RB (clone 16A), CD62L (clone MEL-14), CD69 (clone H1.2F3), Qa2 (clone 1-1-2), and CD90.2 (clone 53-2.1), all from eBioscience or BD Pharmingen. Biotinylated Abs were detected with allophycocyanin-conjugated streptavidin (eBioscience). Events were collected on a FACSCanto flow cytometer (BD Biosciences) and data were analyzed with FlowJo software (Tree Star) after excluding doublets from live-gated samples. Fluorescence-minus-one (5) samples were run where appropriate. For sorting, untouched T cells were enriched with an EasySep kit (StemCell Technologies) and stained to eliminate non-T cell lineages with PE-conjugated anti-CD11b (clone M1/70), anti-NK1.1 (clone PK136), anti-B220 (clone RA3-6B2), and anti-Ter119 (clone Ly-76) (all from eBioscience or BD Biosciences). Staining with anti-CD62L was used as a positive marker for naive cells. Cells were sorted on a FACSAria cell sorter (BD Biosciences) as PE–CD62L+ and either GFP+ or GFP– to >97% purity (for blood sorts, purity was >95% for RTE and >80% for non-RTE).
Quantification of IL-2 secretion and cell proliferation
Per well, 25,000 sorted CD4 T cells were stimulated with 30 ng/ml anti-CD3 and 1 µg/ml anti-CD28 (BD Biosciences) in the presence of 175,000 irradiated splenocytes depleted of T cells by treatment with anti-CD4 (RC172.4R6), anti-CD8 (3.168.8), and anti-CD90.2 (13.4.6) plus rabbit complement (Cedarlane Laboratories). Cells were cultured in 96-well plates (BD Biosciences) in complete RPMI 1640 at 37°C in 7% CO2. IL-2 secretion was measured in 24-h supernatants with the OptEIA IL-2 ELISA kit (BD Biosciences). At 48 h, 1 µCi of [3H]thymidine (PerkinElmer) was added per well, and 3H incorporation was measured after overnight incubation.
| Results and Discussion |
|---|
|
|
|---|
To determine whether the phenotypic changes that occur in RTEs are due to selective survival and outgrowth of a subpopulation of RTEs bearing a mature CD24lowQa2highCD45RBhigh phenotype or to maturation of RTEs on a per cell basis, we adoptively transferred equal numbers of sorted CD4 RTEs and non-RTEs into lymphoreplete recipients. Comparable numbers of both cell types were recovered from recipient spleens short term following transfer (Fig. 1A) and, at
10% of input, were on a par with the generally accepted engraftment of transferred lymphocytes (6). Down-regulation of CD24 and up-regulation of Qa2 and CD45RB expression by RTEs was evident during the 7-day time course, even in undivided populations of RTEs (Fig. 1B). Thus, RTE maturation does not require cell division. The gradual decay of GFP in the transferred RTEs (Fig. 1C) is consistent with the estimated half-life of GFP in T cells (7). At 7 days posttransfer, > 95% RTEs remained GFP+CD44low/midCD62Lhigh and undivided (Fig. 1C and data not shown), arguing against significant homeostatic proliferation. The percentage take and the absence of extensive proliferation together suggest that the phenotypic changes in RTEs result from progressive maturation of the bulk of the RTE population rather than selective accumulation of a subset of RTEs already expressing a mature surface Ag phenotype.
|
To explore whether the RTE maturation that occurs in the periphery is a cell-intrinsic program or one that is triggered by signals from the lymphoid periphery, we sequestered RTEs in the thymus by treating RAG2p-GFP Tg mice with AAL-R (8, 9). AAL-R is a synthetic mimetic of S1P, blocking S1P receptor 1 (S1P1), the receptor that is required for T cell exit from both the thymus and LNs (9, 10). The resulting RTE "wannabes" were contained within the GFP+, developmentally mature (TCRhighCD62Lhigh SP) thymocyte compartments (Fig. 2A). RTE "wannabes" accumulated in the thymus of AAL-R-treated mice, as these most developmentally mature CD4 and CD8 SP compartments increased
5-fold by percentage (Fig. 2B) and
3-fold by number (data not shown) relative to the thymus of untreated mice or mice treated with AAL-S, the biologically inactive enantiomer of AAL-R (8, 9).
|
However, the phenotype of RTE "wannabes" is intermediate, as Qa2 and CD45RB were essentially at mature levels (data not shown). Thus, part of the maturation program may be on autopilot or the factors driving RTE maturation in the periphery may also be present in the thymus, with lack of full maturation of RTE "wannabes" being a result of quantitative rather than qualitative maturation signal differences. This idea is reinforced by the phenotypic maturity of S1P1-deficient T cells that remain stuck in the thymus (11).
AAL-R (and other S1P mimetics such as FTY720) binds to the S1P3, S1P4, and S1P5 receptors as well as to S1P1, influencing factors such as heart rate (12). Our results using the S1P1-specific agonist SEW2871 (13) were comparable to those obtained with AAL-R (data not shown), suggesting that the maturation defects are specific to blockade of thymic egress.
RTE maturation requires access to SLOs
SLOs are the sites where naive T cells encounter many other cell types, such as dendritic cells, and cytokines, such as IL-7 (14). To test whether RTE maturation takes place in SLOs, we blocked RTE access to SLOs through a combination of splenectomy and administration of anti-CD62L plus anti-VLA-4 to block LN entry, creating "homeless" RTEs (Fig. 3A). LN blockade was successful, as 6 days following initiation of Ab administration there was a >50-fold reduction in naive T cell numbers in LNs (data not shown). Phenotypic maturation of GFP-normalized "homeless" RTEs relative to control RTEs was impaired for the markers Qa2 (Fig. 3B) and CD45RB (data not shown). When the Qa2 expression level on "homeless" RTEs was normalized to that of control RTEs, there was a statistically significant difference between "homeless" RTEs and control RTEs for both CD4 and CD8 T cells (p < 0.05, two-tailed Students t test with equal variance). Access to either the spleen or LN compartment alone is sufficient for maturation, as the phenotypic profile of RTEs blocked from either compartment alone matched that of control RTEs (Fig. 3C). Surgical stress and homeostatic proliferation did not influence RTE maturation, as Qa2, CD45RB, and CD44 expression levels in RTEs from splenectomized mice matched those of untreated or Ab-treated mice (Fig. 3C and data not shown). The Abs coating RTEs to block LN entry did not impair maturation, as the phenotypic profile of Ab-coated RTEs in the spleen matches that of uncoated RTEs from the periphery of control mice (Fig. 3C).
|
RTE maturation does not require continuous recirculation in the lymphoid periphery
Naive T cells scan for Ag presented by dendritic cells in SLOs, recirculating to another SLO if Ag is not found within 12–18 h (15). To test whether RTE maturation requires continuous recirculation in the lymphoid periphery, we compared the phenotype of RTEs that were "stuck" in SLOs for 6 days with that of control RTEs continually recirculating for 6 days (Fig. 4A). Because AAL-R treatment blocks thymic egress, we thymectomized control mice at the onset of the experiment to age-match the RTEs in each group and thereby matched GFP levels of "stuck" and control RTEs. There was no statistically significant difference in the CD24 or Qa2 MFIs between "stuck" and control RTEs for either CD4 or CD8 T cells (p = 0.56 to 0.98, two-tailed Students t test with equal variance), indicating that continuous recirculation is not required for RTE maturation (Fig. 4B). To assess RTEs that did not recirculate extensively before AAL-R treatment, we analyzed GFPhigh RTEs from both groups and again found comparable maturation (data not shown).
|
Functional RTE maturation requires access to SLOs
In addition to phenotypic defects, stimulated "homeless" CD4 RTEs secrete less IL-2 (Fig. 5A) and proliferate less relative to control RTEs (Fig. 5B). A similar comparison of "homeless" CD8 RTEs and control non-RTEs was precluded due to small blood volumes and the low proportion of CD8 T cells among RTEs (1). "Homeless" and control CD4 non-RTEs secreted more IL-2 than did control RTEs (Fig. 5A and data not shown), demonstrating that functional defects are limited to RTEs without access to SLOs. Thus, access to SLOs is important for RTEs to complete both phenotypic and functional maturation.
|
and the decrease in CD3 expression levels upon RTE maturation could modulate immunocompetence. Although CD24 has roles in both naive T cell homeostasis (18) and tolerance (19), less is known about the function in T cells of Qa2, a nonclassical class Ib MHC molecule, or CD45RB, an isoform of the CD45 glycoprotein phosphatase (20, 21). Our data do suggest that phenotypic and functional maturation go hand in hand, making phenotypic marker expression a reliable indicator of the overall maturation state of RTEs.
Peripheral maturation was not seen in a study of RTEs labeled 10 days previously by intrathymic CFSE injection (22). At best, this 10-day interim would reveal only subtle differences between these "aged" RTEs and non-RTEs (data not shown). Furthermore, while our analyses of RTEs marked by intrathymic FITC injection recapitulate our findings from the RAG2p-GFP system (data not shown), CFSE injection in our hands often labels some extrathymic T cells. RTEs can also be exclusively identified as CD24highQa2low peripheral T cells, although
85% of RTEs are excluded by this gating system (data not shown).
In conclusion, we show in this study that not only does T cell development continue after thymic egress, but that this process is dynamically regulated. While RTEs are adjusting to the lymphoid periphery, their immune competence is dampened for a period of 2–3 wk and they rely on signals received in SLOs to drive them to the full competence of the non-RTE subset, ready to defend against invading pathogens.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by grants from the Cancer Research Institutes Predoctoral Emphasis Pathway in Tumor Immunology Program (to E.G.H.) and the German foundation Friedrich-Ebert-Stiftung (to R.N.) and by National Institutes of Health Grants R21 AG 023781 and AI 064318 (to P.J.F.). ![]()
2 The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ![]()
3 Current address: Department of Cellular and Molecular Immunology, Max Planck Institute of Immunology, Freiburg 79108, Germany. ![]()
4 Address correspondence and reprint requests to Dr. Pamela Fink, Department of Immunology, University of Washington, I-607H Health Sciences Center, Box 357650, 1959 Northeast Pacific Street, Seattle, WA 98195. E-mail address: pfink{at}u.washington.edu ![]()
5 Abbreviations used in this paper: RTE, recent thymic emigrant; AAL-R, 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol; AAL-S, biologically inactive enantiomer of AAL-R; LN, lymph node; MFI, mean fluorescence intensity; SLO, secondary lymphoid organ; S1P, sphingosine 1-phosphate; S1P1, sphingosine 1-phosphate receptor 1; SP, single positive; Tg, transgenic; VLA-4, very late Ag 4. ![]()
Received for publication July 8, 2008. Accepted for publication August 19, 2008.
| References |
|---|
|
|
|---|
4f/f mice are hematopoietic cell autonomous. Blood 109: 109-111. This article has been cited by other articles:
![]() |
E. G. Houston Jr. and P. J. Fink MHC Drives TCR Repertoire Shaping, but not Maturation, in Recent Thymic Emigrants J. Immunol., December 1, 2009; 183(11): 7244 - 7249. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Makaroff, D. W. Hendricks, R. E. Niec, and P. J. Fink Postthymic maturation influences the CD8 T cell response to antigen PNAS, March 24, 2009; 106(12): 4799 - 4804. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |